President Trump previously said the administration would “negotiate like crazy” when it came to drug prices and refrained from criticizing a bill introduced by House Speaker Nancy Pelosi, D-Calif., that would allow Medicare to negotiate with pharmaceutical companies, according to the report.
That is until Nov. 22, when the president took to Twitter to voice his concerns with the bill. The Hill points to a Nov. 21 meeting between President Trump and Rep. Greg Walden, R-Ore., who has been a vocal opponent of the plan, as the turning point.
Instead, a Senate bipartisan drug pricing bill that would cap out-of-pocket costs and price increases has caught President Trump’s eye, according to the report.
Read more here.
More articles on pharmacy:
PhRMA to end funding of addiction treatment group next year
10 hospitals seeking pharmacy leaders
Ohio adds breach of contract charges to lawsuit against OptumRx
